North Carolina Biotech Networks
  • Home
  • About
  • News
    • All News
    • Trending News
  • Jobs
    • All Jobs
    • Post a Job
  • Subscribe
  • Contact
News Ticker
  • [ February 8, 2023 ] Chapel Hill medtech laying off 48 workers as sell off looms News
  • [ February 8, 2023 ] How Purdue’s $272M addiction payout funded a new home for its discarded non-opioid research News
  • [ February 8, 2023 ] Morrisville firm serving life sciences expands in Europe News
  • [ February 7, 2023 ] Triangle pharma raising millions amid uncertain future News
  • [ February 7, 2023 ] STAT+: Former Sen. Richard Burr to join health care practice at law and lobbying firm News
HomeNews

News

No Picture
News

Chapel Hill medtech laying off 48 workers as sell off looms

February 8, 2023 ncbiotech Comments Off on Chapel Hill medtech laying off 48 workers as sell off looms

A medical device company in Chapel Hill is laying off most of its staff after it failed to find a buyer. Click here to view original post

No Picture
News

How Purdue’s $272M addiction payout funded a new home for its discarded non-opioid research

February 8, 2023 ncbiotech Comments Off on How Purdue’s $272M addiction payout funded a new home for its discarded non-opioid research

Don Kyle spent more than 20 years working for Purdue Pharma, right through the US opioid epidemic that led to the company’s rise and eventual infamy. But contrary to Purdue’s focus on OxyContin, Kyle was […]

No Picture
News

Morrisville firm serving life sciences expands in Europe

February 8, 2023 ncbiotech Comments Off on Morrisville firm serving life sciences expands in Europe

A fast-growing life sciences organization in Morrisville is targeting the European market for growth. Click here to view original post

No Picture
News

Triangle pharma raising millions amid uncertain future

February 7, 2023 ncbiotech Comments Off on Triangle pharma raising millions amid uncertain future

Tenax Therapeutics has initiated a public offering as the company seeks a viable path forward. Click here to view original post

No Picture
News

STAT+: Former Sen. Richard Burr to join health care practice at law and lobbying firm

February 7, 2023 ncbiotech Comments Off on STAT+: Former Sen. Richard Burr to join health care practice at law and lobbying firm

Former Senate health committee Republican leader Richard Burr will be starting a new health care practice at a well-known Washington law and lobbying firm. Click here to view original post

No Picture
News

Hatteras Venture Partners raises $126M fund with room for much more

February 7, 2023 ncbiotech Comments Off on Hatteras Venture Partners raises $126M fund with room for much more

One of North Carolina’s biggest venture capital firms has closed on its seventh fund. Click here to view original post

No Picture
News

Danaher approached contract manufacturer Catalent about acquisition – report

February 6, 2023 ncbiotech Comments Off on Danaher approached contract manufacturer Catalent about acquisition – report

The life science conglomerate Danaher Corporation may have an interest in a major name in US contract manufacturing. A report from Bloomberg over the weekend said that Danaher has expressed some interest in acquiring New […]

No Picture
News

Vaccine maker in RTP shuts down in wake of layoffs

February 6, 2023 ncbiotech Comments Off on Vaccine maker in RTP shuts down in wake of layoffs

Months after laying off employees at its Research Triangle Park facility, Canadian vaccine maker Medicago is shutting down for good. Click here to view original post

No Picture
News

Freight forwarder DHL makes $8M bet on Triangle pharma

February 6, 2023 ncbiotech Comments Off on Freight forwarder DHL makes $8M bet on Triangle pharma

DHL Global Forwarding is opening a new warehouse facility in Durham as the Triangle’s life sciences sector continues to rise. Click here to view original post

No Picture
News

Lucius Partners Announces the Addition of Centaur Bio, Inc. to the Portfolio

February 6, 2023 ncbiotech Comments Off on Lucius Partners Announces the Addition of Centaur Bio, Inc. to the Portfolio

Centaur’s precision medicine technology, licensed from Duke University School of Medicine, transports difficult to deliver agents across the blood brain barrier. Multiple Oncology and CNS indications; first IND expected to be open in Q2 of […]

Posts navigation

1 2 … 55 »
POST A JOB

Tweets by NCBionetworks

Copyright © 2022 Biotech Networks